BioCentury
ARTICLE | Financial News

Cytovax prices IPO

February 21, 2001 8:00 AM UTC

Infectious disease play Cytovax (TSE:CXB.A) raised C$10 million (US$6.5 million) in its IPO through the sale of 1.7 million shares at C$6. The deal, which has a 250,005-share overallotment, was underw...